Dont Stop Semaglutide Abruptly If youre considering stopping the medication due to side effects, talk to your provider first
Broadly similar GI profile but the glucagon receptor activation means heart rate needs closer monitoring
DAmico D, Andreux PA, Valds P, Singh A, Rinsch C, Auwerx J
adults currently take a GLP-1 for weight loss (up from 3 percent in 2024 and 8 percent in 2025) 15 percent have used a GLP-1 medication for weight loss at some point 68 percent of current users take brand-name medications such as Ozempic, Wegovy, or Zepbound 19 percent take compounded or custom-mixed GLP-1 versions not approved by the FDA 91 percent of Americans now know GLP-1 drugs can be used for weight loss (up from 80 percent in 2024) The Medicare GLP-1 Bridge, administered by the Centers for Medicare and Medicaid Services (CMS), is a demonstration program operating outside the standard Part D benefit
doi: 10.2337/dc25-0690 23 FurihataKMimuraHUrvaSOuraTOhwakiKImaokaT